These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6461458)

  • 1. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
    Hotta R; Kuriki J; Kakumu S
    Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
    Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
    Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of suppressor function of human peripheral blood T cells by (+)cyanidanol-3: its application to chronic active liver diseases.
    Kakumu S; Murakami H; Kuriki J
    Clin Exp Immunol; 1983 May; 52(2):430-6. PubMed ID: 6222856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concanavalin A induced suppression of lymphocyte proliferation in chronic liver disease. A study of suppressor and responder populations in autologous and allogeneic systems.
    Arabi MA; Nouri-Aria KT; Alexander GJ; Eddleston AL; Williams R
    J Clin Lab Immunol; 1985 Dec; 18(4):161-5. PubMed ID: 2937919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T suppressor cell function and number in children with liver disease.
    Nouri-Aria KT; Lobo-Yeo A; Vergani D; Mieli-Vergani G; Eddleston AL; Mowat AP
    Clin Exp Immunol; 1985 Aug; 61(2):283-9. PubMed ID: 2931221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum rosette inhibitory factors in chronic liver disease.
    Zauli D; Bianchi FB; Fusconi M; Crespi C; Pisi E
    Clin Exp Immunol; 1983 Jul; 53(1):145-50. PubMed ID: 6603304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.
    Nouri-Aria KT; Alexander GJ; Portmann B; Vergani D; Eddleston AL; Williams R
    Clin Exp Immunol; 1986 Apr; 64(1):50-8. PubMed ID: 2942323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.
    Yoshioka K; Kakumu S; Murakami H; Fukui K
    Clin Exp Immunol; 1984 Jun; 56(3):669-76. PubMed ID: 6235072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased peripheral blood Ia positive T cells and their effect on autologous mixed lymphocyte reaction in chronic active liver disease.
    Fukui K; Kakumu S; Murakami H; Kuriki J; Yoshioka K; Sakamoto N
    Clin Exp Immunol; 1984 Oct; 58(1):90-6. PubMed ID: 6236920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor cell activity in viral and non-viral chronic active hepatitis.
    Tremolada F; Fattovich G; Panebianco G; Ongaro G; Realdi G
    Clin Exp Immunol; 1980 Apr; 40(1):89-95. PubMed ID: 6446433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
    Aureli G; Battista V; Bianchi L; Bolzonetti A; Cipriani A; Carnevali GF; Caschera F; Caputo B; Danieli G; Corvetta A
    Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disordered immunoregulatory functions in patients with chronic active hepatitis.
    Nonomura A; Tanino M; Kurumaya H; Ohta G; Kato Y; Kobayashi K
    Clin Exp Immunol; 1982 Mar; 47(3):595-605. PubMed ID: 6211306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte suppressor cell activity in acute and chronic liver disease.
    Kashio T; Hotta R; Kakumu S
    Clin Exp Immunol; 1981 Jun; 44(3):459-66. PubMed ID: 6459894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
    Fairchild RS; Kyner JL; Abdou NI
    J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory T-cell function in acute and chronic liver disease.
    Kakumu S; Yata K; Kashio T
    Gastroenterology; 1980 Oct; 79(4):613-9. PubMed ID: 6967838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction of the suppressor response induced by con A in patients with hemophilia A or B].
    Fernández J; Sasiain MC; Ruibal-Ares B; De la Barrera S; Felippo M; Riera N; Fejes M; Pérez Bianco RR; De Bracco MM; De Tezanos Pinto M
    Sangre (Barc); 1986; 31(1):7-16. PubMed ID: 2939575
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
    Araki K; Nagashima H; Tsuji T
    Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.